AAAAAA

   
Results: 1-17 |
Results: 17
Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis
Authors: Vaziri, SAJ Krumroy, LM Elson, P Budd, GT Darlington, G Myles, J Tubbs, RR Casey, G
Citation: Saj. Vaziri et al., Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis, CLIN CANC R, 7(7), 2001, pp. 1937-1945
Chemotherapy for acute myelogenous leukemia in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factor
Authors: Kalaycio, M Pohlman, B Elson, P Lichtin, A Hussein, M Tripp, B Andresen, S
Citation: M. Kalaycio et al., Chemotherapy for acute myelogenous leukemia in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factor, AM J CL ONC, 24(1), 2001, pp. 58-63
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma
Authors: Olencki, T Peereboom, D Wood, L Budd, GT Novick, A Finke, J McLain, D Elson, P Bukowski, RM
Citation: T. Olencki et al., Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma, J CANC RES, 127(5), 2001, pp. 319-324
GM-CSF safety and effects in the management of advanced/refractory multiple myeloma patients: a phase I trial
Authors: Hussein, MA Sandstrom, K Elson, P Finke, J McLain, D Rayman, P Rybicki, LA Bukowski, RA
Citation: Ma. Hussein et al., GM-CSF safety and effects in the management of advanced/refractory multiple myeloma patients: a phase I trial, J CANC RES, 127(10), 2001, pp. 619-624
Shanxi province cervical cancer screening study: A cross-sectional comparative trial of multiple techniques to detect cervical neoplasia
Authors: Belinson, J Qiao, YL Pretorius, R Zhang, WH Elson, P Li, L Pan, QJ Fischer, C Lorincz, A Zahniser, D
Citation: J. Belinson et al., Shanxi province cervical cancer screening study: A cross-sectional comparative trial of multiple techniques to detect cervical neoplasia, GYNECOL ONC, 83(2), 2001, pp. 439-444
Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases
Authors: Shen, ZZ Wu, MZ Elson, P Kennedy, AW Belinson, J Casey, G Xu, Y
Citation: Zz. Shen et al., Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases, GYNECOL ONC, 83(1), 2001, pp. 25-30
Cervical cancer screening by simple visual inspection after acetic acid
Authors: Belinson, JL Pretorius, RG Zhang, WH Wu, LY Qiao, YL Elson, P
Citation: Jl. Belinson et al., Cervical cancer screening by simple visual inspection after acetic acid, OBSTET GYN, 98(3), 2001, pp. 441-444
The colposcopic impression - Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?
Authors: Pretorius, RG Belinson, JL Zhang, WH Burchette, RJ Elson, P Qiao, YL
Citation: Rg. Pretorius et al., The colposcopic impression - Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?, J REPRO MED, 46(8), 2001, pp. 724-728
Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease
Authors: Milsom, JW Hammerhofer, KA Bohm, B Marcello, P Elson, P Fazio, VW
Citation: Jw. Milsom et al., Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease, DIS COL REC, 44(1), 2001, pp. 1-8
Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease - The authors reply
Authors: Milsom, JW Hammerhofer, KA Bohm, B Marcello, P Elson, P Fazio, VW
Citation: Jw. Milsom et al., Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease - The authors reply, DIS COL REC, 44(1), 2001, pp. 9-9
Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: Clinical and biologic effects
Authors: Olencki, T Finke, J Tubbs, R Elson, P McLain, D Herzog, P Budd, GT Gunn, H Bukowski, RM
Citation: T. Olencki et al., Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: Clinical and biologic effects, J IMMUNOTH, 23(5), 2000, pp. 549-556
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis
Authors: van Stolk, R Stoner, G Hayton, WL Chan, K DeYoung, B Kresty, L Kemmenoe, BH Elson, P Rybicki, L Church, J Provencher, K McLain, D Hawk, E Fryer, B Kelloff, G Ganapathi, R Budd, GT
Citation: R. Van Stolk et al., Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis, CLIN CANC R, 6(1), 2000, pp. 78-89
Phase II trial of liposomal doxorubicin (Doxil (R)) in advanced soft tissue sarcomas
Authors: Chidiac, T Budd, GT Pelley, R Sandstrom, K McLain, D Elson, P Crownover, R Marks, K Muschler, G Joyce, M Zehr, R Bukowski, R
Citation: T. Chidiac et al., Phase II trial of liposomal doxorubicin (Doxil (R)) in advanced soft tissue sarcomas, INV NEW DR, 18(3), 2000, pp. 253-259
Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: Evidence of impaired secretion in response to interleukin-12
Authors: Ulchaker, J Panuto, J Rayman, P Novick, A Elson, P Tubbs, R Finke, JH Bukowski, RM
Citation: J. Ulchaker et al., Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: Evidence of impaired secretion in response to interleukin-12, J IMMUNOTH, 22(1), 1999, pp. 71-79
Prevalence of cervical cancer and feasibility of screening in rural China:a pilot study for the Shanxi Province Cervical Cancer Screening Study
Authors: Belinson, J Qiao, Y Pretorius, R Zhang, W Keaton, K Elson, P Fischer, C Lorincz, A Zahniser, D Wilbur, D Pan, Q Li, L Biscotti, C Dawson, A Li, A Wu, L Ling, Y Ma, CP Yang, XP
Citation: J. Belinson et al., Prevalence of cervical cancer and feasibility of screening in rural China:a pilot study for the Shanxi Province Cervical Cancer Screening Study, INT J GYN C, 9(5), 1999, pp. 411-417
Clinical features of hypersensitivity reactions to carboplatin
Authors: Markman, M Kennedy, A Webster, K Elson, P Peterson, G Kulp, B Belinson, J
Citation: M. Markman et al., Clinical features of hypersensitivity reactions to carboplatin, J CL ONCOL, 17(4), 1999, pp. 1141-1145
Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer
Authors: Rajagopalan, K Peereboom, D Budd, GT Olencki, T Murthy, S Elson, P McLain, D Bukowski, R
Citation: K. Rajagopalan et al., Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer, INV NEW DR, 16(3), 1998, pp. 255-258
Risultati: 1-17 |